LeadIQ logo
Learn more at LeadIQ.com

Insights

Expanding Global Reach Henlius's active collaborations with international partners such as Sandoz, Abbott, and Lotus Pharma demonstrate a strong push into emerging markets like Latin America and the Middle East, presenting opportunities to introduce complementary biosimilar and oncology products.

Robust Oncology Portfolio With six launched biologics and a focus on innovative treatments for oncology and rare diseases like Thymic Epithelial Tumors, Henlius exhibits a significant market presence that could benefit from advanced supply chain solutions and specialized healthcare services.

Market Recognition Repeated accolades as one of Asia's best workplaces and attractive employers suggest a motivated, stable workforce, which can be leveraged for collaborations in employee training, biotech innovation programs, or regional commercialization initiatives.

Financial & Funding Outlook With revenue between $250M and $500M and recent funding of $156M, Henlius is poised for growth, offering opportunities for strategic investments, capability enhancement, and partnership in biosimilar development and distribution.

Technological Infrastructure Utilization of advanced tech stack including Alibaba Cloud CDN and Microsoft ASP.NET indicates modern IT capabilities, enabling potential sales of digital health solutions, data management services, or cloud infrastructure support tailored for biotech companies.

Shanghai Henlius Biotech, Inc. (2696.HK) Tech Stack

Shanghai Henlius Biotech, Inc. (2696.HK) uses 7 technology products and services including Alibaba Cloud CDN, jQuery, Windows Server, and more. Explore Shanghai Henlius Biotech, Inc. (2696.HK)'s tech stack below.

  • Alibaba Cloud CDN
    Content Delivery Network
  • jQuery
    Javascript Libraries
  • Windows Server
    Operating Systems
  • Bootstrap
    UI Frameworks
  • Tengine
    Web And Application Servers
  • Microsoft ASP.NET
    Web Frameworks
  • Microsoft IIS
    Web Servers

Media & News

Shanghai Henlius Biotech, Inc. (2696.HK)'s Email Address Formats

Shanghai Henlius Biotech, Inc. (2696.HK) uses at least 1 format(s):
Shanghai Henlius Biotech, Inc. (2696.HK) Email FormatsExamplePercentage
First_Last@henlius.comJohn_Doe@henlius.com
49%
First_L@henlius.comJohn_D@henlius.com
1%
First_Last@henlius.comJohn_Doe@henlius.com
49%
First_L@henlius.comJohn_D@henlius.com
1%

Frequently Asked Questions

Where is Shanghai Henlius Biotech, Inc. (2696.HK)'s headquarters located?

Minus sign iconPlus sign iconShanghai Henlius Biotech, Inc. (2696.HK)'s main headquarters is located at No.188 Yizhou Rd, Xuhui District, Shanghai, Shanghai 200233, CN. The company has employees across 4 continents, including AsiaNorth AmericaOceania.

What is Shanghai Henlius Biotech, Inc. (2696.HK)'s phone number?

Minus sign iconPlus sign icon You can contact Shanghai Henlius Biotech, Inc. (2696.HK)'s main corporate office by phone at
+86-21-3339-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Shanghai Henlius Biotech, Inc. (2696.HK)'s stock symbol?

Minus sign iconPlus sign iconShanghai Henlius Biotech, Inc. (2696.HK) is a publicly traded company; the company's stock symbol is 2696.HK.

What is Shanghai Henlius Biotech, Inc. (2696.HK)'s official website and social media links?

Minus sign iconPlus sign iconShanghai Henlius Biotech, Inc. (2696.HK)'s official website is henlius.com and has social profiles on LinkedInCrunchbase.

What is Shanghai Henlius Biotech, Inc. (2696.HK)'s SIC code NAICS code?

Minus sign iconPlus sign iconShanghai Henlius Biotech, Inc. (2696.HK)'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Shanghai Henlius Biotech, Inc. (2696.HK) have currently?

Minus sign iconPlus sign iconAs of October 2025, Shanghai Henlius Biotech, Inc. (2696.HK) has approximately 1K employees across 4 continents, including AsiaNorth AmericaOceania. Key team members include Chief Executive Officer: J. Z.Chief Technology Officer: S. H.Chief Officer, Chairman Office: V. Z.. Explore Shanghai Henlius Biotech, Inc. (2696.HK)'s employee directory with LeadIQ.

What industry does Shanghai Henlius Biotech, Inc. (2696.HK) belong to?

Minus sign iconPlus sign iconShanghai Henlius Biotech, Inc. (2696.HK) operates in the Biotechnology Research industry.

What technology does Shanghai Henlius Biotech, Inc. (2696.HK) use?

Minus sign iconPlus sign iconShanghai Henlius Biotech, Inc. (2696.HK)'s tech stack includes Alibaba Cloud CDNjQueryWindows ServerBootstrapTengineMicrosoft ASP.NETMicrosoft IIS.

What is Shanghai Henlius Biotech, Inc. (2696.HK)'s email format?

Minus sign iconPlus sign iconShanghai Henlius Biotech, Inc. (2696.HK)'s email format typically follows the pattern of First_Last@henlius.com. Find more Shanghai Henlius Biotech, Inc. (2696.HK) email formats with LeadIQ.

How much funding has Shanghai Henlius Biotech, Inc. (2696.HK) raised to date?

Minus sign iconPlus sign icon As of October 2025, Shanghai Henlius Biotech, Inc. (2696.HK) has raised $156M in funding. The last funding round occurred on Jul 20, 2018 for $156M.

When was Shanghai Henlius Biotech, Inc. (2696.HK) founded?

Minus sign iconPlus sign iconShanghai Henlius Biotech, Inc. (2696.HK) was founded in 2010.
Shanghai Henlius Biotech, Inc. (2696.HK)

Shanghai Henlius Biotech, Inc. (2696.HK)

Biotechnology ResearchChina1001-5000 Employees

Henlius is a rapidly growing biopharmaceutical provider that develops, manufactures, and distributes leading oncology treatments. Our talented team brings experience from all sectors of the pharmaceutical industry to deliver more effective and affordable treatments for over 800,000 patients in over 50 countries. 

Our mission is to provide effective treatments in oncology and other diseases that allow people regain their healthy lives. 

Learn more at www.henlius.com/en/Index.html

Section iconCompany Overview

Headquarters
No.188 Yizhou Rd, Xuhui District, Shanghai, Shanghai 200233, CN
Phone number
+86-21-3339-****
Website
henlius.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
2696.HK
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
1001-5000

Section iconMedia & News

Section iconFunding & Financials

  • $156M

    Shanghai Henlius Biotech, Inc. (2696.HK) has raised a total of $156M of funding over 3 rounds. Their latest funding round was raised on Jul 20, 2018 in the amount of $156M.

  • $250M$500M

    Shanghai Henlius Biotech, Inc. (2696.HK)'s revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $156M

    Shanghai Henlius Biotech, Inc. (2696.HK) has raised a total of $156M of funding over 3 rounds. Their latest funding round was raised on Jul 20, 2018 in the amount of $156M.

  • $250M$500M

    Shanghai Henlius Biotech, Inc. (2696.HK)'s revenue is estimated to be in the range of $250M$500M

Company Leadership

  • Stylized image of a person
    J. Z.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. H.
    Chief Technology Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    V. Z.
    Chief Officer, Chairman Office
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. Q.
    Head Of Compensation & Benefits
    Phone icon
    Mobile Phone
  • Stylized image of a person
    W. Z.
    Chairman And Ceo
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    R. L.
    Director, Head Of Frontier Drug Discovery
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. Q.
    Head Of Compensation & Benefits
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. C.
    Pharmacovigilance Associate Director
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. T.
    Clinical Project Management Director
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. Y.
    Executive Director, Clinical Quality Assurance
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.